Earnings Call · Q4 FY2025·2026-03-12

Q4 25EPS +100.00%*·Rev n/aQ3 25EPS +33.33%·Rev n/aQ2 25EPS +22.22%·Rev n/aQ1 25EPS 0.00%·Rev n/a⚠ consensus missing

Vaxart, Inc. VXRT

Ed Berg — SVP, General Counsel

Steven Lo — President, Chief Exec Officer

James F. Cummings — Chief Medical Officer

Sean N. Tucker — SVP, Chief Scientific Officer

Jeroen Grasman — Chief Financial Officer

−14.9%1d on move date−14.3% vs SPY3d−8.1%5d−12.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VXRT calls or request research access.

More VXRT calls Browse calls Request research access